# OnCo record vulvar-melanoma (cancer). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/cancers/vulvar-melanoma/>
  a schema:MedicalCondition ;
  onco:kind "cancer" ;
  schema:identifier "vulvar-melanoma" ;
  schema:name "Vulvar melanoma"@en ;
  schema:alternateName "Primary vulvar melanoma"@en, "Melanoma of the vulva"@en, "Vulvovaginal melanoma (with vaginal melanoma)"@en ;
  schema:description "Vulvar melanoma is the second most common vulvar cancer, a melanoma of the mucosal skin of the vulva in older women that is usually found late and has a poorer outlook than skin melanoma. It is removed with a margin, staged like skin melanoma by thickness, and treated when advanced with the immunotherapy and, for the quarter with a BRAF or KIT mutation, the targeted drugs used for other melanomas."@en ;
  schema:url <https://onco.cc/cancers/vulvar-melanoma/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Vulvar_cancer> ;
  schema:citation <https://www.cancer.gov/types/vulvar/treatment>, <https://doi.org/10.1158/1078-0432.ccr-16-2126>, <https://doi.org/10.3892/ijmm.2014.1659>, <https://doi.org/10.1002/cncr.30473>, <https://doi.org/10.1097/cmr.0b013e32833684e8> ;
  onco:tag "subtype-page", "wave4", "rare" ;
  onco:related <https://onco.cc/cancers/vulvar/>, <https://onco.cc/cancers/vaginal-melanoma/>, <https://onco.cc/cancers/mucosal-melanoma/>, <https://onco.cc/cancers/melanoma/>, <https://onco.cc/cancers/urethral-melanoma/>, <https://onco.cc/cancers/bartholin-gland-carcinoma/> ;
  onco:targets <https://onco.cc/targets/braf/>, <https://onco.cc/targets/kit/> ;
  onco:drugs <https://onco.cc/drugs/nivolumab/>, <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/drugs/ipilimumab/>, <https://onco.cc/drugs/imatinib/> ;
  onco:standardOfCare <https://onco.cc/cancers/vulvar/>, <https://onco.cc/cancers/mucosal-melanoma/>, <https://onco.cc/drugs/nivolumab/>, <https://onco.cc/drugs/pembrolizumab/>, <https://onco.cc/drugs/ipilimumab/>, <https://onco.cc/drugs/imatinib/> .
